EP2552456

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    29.3.2011
  • EP published:
    23.8.2017
  • EP application number:
    11763336.2
  • Max expiry date:
    28.3.2031
  • Title:
    SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

Timeline

Today
29.3.2011EP application
23.8.2017EP Publication

Owner

  • Name:
    Alnylam Pharmaceuticals, Inc.
  • Address:
    300 Third Street, 3rd Floor, 02142, Cambridge, MA, US
  • Name:
    Kumamoto University
  • Address:
    39-1 Kurokami 2-chome, 860-8555, Kumamoto-shiKumamoto, JP

Inventor

  • Name:
    ANDO, Yukio
  • Address:
    Kumamoto, JP
  • Name:
    JONO, Hirofumi
  • Address:
    Kumamoto, JP
  • Name:
    ALVAREZ, Rene
  • Address:
    Cambridge, MA, US
  • Name:
    SAH, Dinah, Wen-Yee
  • Address:
    Cambridge, MA, US

Priority

  • Number:
    318702 P
  • Date:
    29.3.2010
  • Country:
    US
  • Number:
    318704 P
  • Date:
    29.3.2010
  • Country:
    US

Classification

  • Categories:
    A61K 31/7088, C07H 21/02, A61K 48/00, A61K 31/7115, A61K 31/713, C12N 15/113, A61P 27/02

Upload documents